Display options
Cite
Matulewicz RS, Bassett JC, Kwan L, et al. Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study. Cancer. 2021;doi: 10.1002/cncr.34054.
Matulewicz, R. S., Bassett, J. C., Kwan, L., Sherman, S. E., McCarthy, W. J., Saigal, C. S., & Gore, J. L. (2021). Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study. Cancer, . https://doi.org/10.1002/cncr.34054
Matulewicz, Richard S, et al. "Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study." Cancer vol. (2021). doi: https://doi.org/10.1002/cncr.34054
Matulewicz RS, Bassett JC, Kwan L, Sherman SE, McCarthy WJ, Saigal CS, Gore JL. Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study. Cancer. 2021 Dec 07; doi: 10.1002/cncr.34054. Epub 2021 Dec 07. PMID: 34875105.
Copy Download .nbib Format: NLM
Share it on

Cancer. 2021 Dec 07; doi: 10.1002/cncr.34054. Epub 2021 Dec 07.

Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study.

Cancer

Richard S Matulewicz, Jeffrey C Bassett, Lorna Kwan, Scott E Sherman, William J McCarthy, Christopher S Saigal, John L Gore

Affiliations

  1. Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  2. VA New York Harbor Healthcare System, New York, New York.
  3. Hoag Urologic Oncology, Hoag Health Network, Newport Beach, California.
  4. Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  5. Department of Population Health, New York University, New York, New York.
  6. Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California.
  7. Department of Psychology, University of California Los Angeles, Los Angeles, California.
  8. Department of Urology, University of Washington School of Medicine, Seattle, Washington.

PMID: 34875105 DOI: 10.1002/cncr.34054

Abstract

BACKGROUND: Urologists frequently treat patients for tobacco-related conditions but infrequently engage in evidence-based practices (EBPs) that screen for and treat tobacco use. Improving the use of EBPs will help to identify smokers, promote cessation, and improve patients' health outcomes.

METHODS: A prospective type I hybrid effectiveness-implementation study was performed to test the feasibility and effectiveness of using a multilevel implementation strategy to improve the use of tobacco EBPs. All urology providers at outpatient urology clinics within the Veterans Health Administration Greater Los Angeles and all patients presenting for a new urology consultation were included. The primary outcome was whether a patient was screened for tobacco use at the time of consultation. Secondary outcomes included a patient's willingness to quit, chosen quit strategy, and subsequent engagement in quit attempts.

RESULTS: In total, 5706 consecutive veterans were seen for a new consultation during the 30-month study period. Thirty-six percent of all visits were for a tobacco-related urologic diagnosis. The percentage of visits that included tobacco use screening increased from 18% (before implementation) to 57% in the implementation phase and to 60% during the maintenance phase. There was significant provider-level variation in adherence to screening. Of all screened patients, 38% were willing to quit, and most patients chose a "cold turkey" method; 22% of the patients elected referral to a formal smoking cessation clinic, and 24% chose telephone counseling. Among those willing to quit, 39% and 49% made a formal quit attempt by 3 and 6 months, respectively.

CONCLUSIONS: A strategy that includes provider education and a customized clinical decision support tool can facilitate provider use of tobacco EBPs in a surgery subspecialty clinic.

© 2021 American Cancer Society.

Keywords: cigarette smoking; implementation science; smoking cessation; urology

References

  1. Bernstein AP, Bjurlin MA, Sherman SE, Makarov DV, Rogers E, Matulewicz RS. Tobacco screening and treatment during outpatient urology office visits in the United States. J Urol. 2021;205:1755-1761. doi:10.1097/ju.0000000000001572 - PubMed
  2. Bjurlin MA, Cohn MR, Kim DY, et al. Brief smoking cessation intervention: a prospective trial in the urology setting. J Urol. 2013;189:1843-1849. doi:10.1016/j.juro.2012.11.075 - PubMed
  3. Bassett JC, Gore JL, Chi AC, et al. Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol. 2012;30:1871-1878. doi:10.1200/jco.2011.36.6518 - PubMed
  4. Bassett JC, Gore JL, Kwan L, et al. Knowledge of the harms of tobacco use among patients with bladder cancer. Cancer. 2014;120:3914-3922. doi:10.1002/cncr.28915 - PubMed
  5. Bassett JC, Matulewicz RS, Kwan L, McCarthy WJ, Gore JL, Saigal CS. Prevalence and correlates of successful smoking cessation in bladder cancer survivors. Urology. 2021;153:236-243. doi:10.1016/j.urology.2020.12.033 - PubMed
  6. Matulewicz RS, Basak R, Zambrano I, et al. Patterns of current cigarette smoking, quit attempts, and cessation counseling among survivors of smoking related and non-smoking related urologic malignancies: a nationally representative cross-sectional analysis. J Urol. 2021;205:1444-1451. doi:10.1097/ju.0000000000001483 - PubMed
  7. Rink M, Crivelli JJ, Shariat SF, Chun FK, Messing EM, Soloway MS. Smoking and bladder cancer: a systematic review of risk and outcomes. Eur Urol Focus. 2015;1:17-27. doi:10.1016/j.euf.2014.11.001 - PubMed
  8. Sosnowski R, Bjurlin MA, Verze P, et al. Role of cigarette smoking in urological malignancies and clinical interventions for smoking cessation. Cent European J Urol. 2016;69:366-369. doi:10.5173/ceju.2016.883 - PubMed
  9. Cacciamani GE, Ghodoussipour S, Mari A, et al. Association between smoking exposure, neoadjuvant chemotherapy response and survival outcomes following radical cystectomy: systematic review and meta-analysis. J Urol. 2020;204:649-660. doi:10.1097/ju.0000000000000813 - PubMed
  10. Tellini R, Mari A, Muto G, et al. Impact of smoking habit on perioperative morbidity in patients treated with radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysis. Eur Urol Oncol. 2021;4:580-593. doi:10.1016/j.euo.2020.10.006 - PubMed
  11. Gild P, Vetterlein MW, Seiler R, et al. The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer-a prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) Urothelial Carcinoma Working Group. Surg Oncol. 2020;34:312-317. doi:10.1016/j.suronc.2020.06.006 - PubMed
  12. Matulewicz RS, Makarov DV, Sherman SE, Birken SA, Bjurlin MA. Urologist-led smoking cessation: a way forward through implementation science. Transl Androl Urol. 2021;10:7-11. doi:10.21037/tau-20-1204 - PubMed
  13. Adams JM. Smoking cessation-progress, barriers, and new opportunities: the surgeon general's report on smoking cessation. JAMA. 2020;323:2470-2471. doi:10.1001/jama.2020.6647 - PubMed
  14. Shields PG. New NCCN guidelines: smoking cessation for patients with cancer. J Natl Compr Canc Netw. 2015;13(suppl):643-645. doi:10.6004/jnccn.2015.0191 - PubMed
  15. Shields PG, Herbst RS, Arenberg D, et al. Smoking cessation, version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:1430-1468. doi:10.6004/jnccn.2016.0152 - PubMed
  16. Bjurlin MA, Goble SM, Hollowell CM. Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol. 2010;184:1901-1906. doi:10.1016/j.juro.2010.06.140 - PubMed
  17. Matulewicz RS, Bjurlin MA, Feuer Z, et al. A population-level assessment of smoking cessation following a diagnosis of tobacco- or nontobacco-related cancer among United States adults. J Smok Cessat. 2021;2021:6683014. doi:10.1155/2021/6683014 - PubMed
  18. Zhao C, Bjurlin MA, Roberts T, Rink M, Shariat SF, Matulewicz RS. A systematic review and scoping analysis of smoking cessation after a urologic cancer diagnosis. J Urol. 2021;205:1275-1285. doi:10.1097/ju.0000000000001641 - PubMed
  19. Bernstein SL, Weiss J, DeWitt M, et al. A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical results. Implement Sci. 2019;14:8. doi:10.1186/s13012-019-0856-8 - PubMed
  20. McQueen L, Mittman BS, Demakis JG. Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI). J Am Med Inform Assoc. 2004;11:339-343. doi:10.1197/jamia.m1499 - PubMed
  21. Stetler CB, Mittman BS, Francis J. Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI series. Implement Sci. 2008;3:8. doi:10.1186/1748-5908-3-8 - PubMed
  22. Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(suppl 1):I17-I25. - PubMed
  23. Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38:65-76. doi:10.1007/s10488-010-0319-7 - PubMed
  24. 2010 VHA Facility Quality and Safety Report. US Department of Veteran Affairs. Published October 2010. Accessed January 2, 2021. https://www.va.gov/health/docs/hospitalreportcard2010.pdf - PubMed
  25. Office of the Surgeon General. Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services; 2020. Accessed January 2, 2021. https://www.hhs.gov/surgeongeneral/reports-and-publications/tobacco/2020-cessation-sgr-factsheet-keyfindings/index.html - PubMed
  26. Myrie AK, Matulewicz RS. Perceptions of the link between smoking and bladder cancer among United States adults. J Urol. 2021;205:324-326. doi:10.1097/ju.0000000000001415 - PubMed
  27. Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149:200-211. doi:10.1177/0194599813490886 - PubMed
  28. D'Angelo H, Hooper MW, Burris JL, et al. Achieving equity in the reach of smoking cessation services within the NCI Cancer Moonshot-funded Cancer Center Cessation Initiative. Health Equity. 2021;5:424-430. doi:10.1089/heq.2020.0157 - PubMed
  29. Burgess DJ, van Ryn M, Noorbaloochi S, et al. Smoking cessation among African American and White smokers in the Veterans Affairs health care system. Am J Public Health. 2014;104(suppl 4):S580-S587. doi:10.2105/ajph.2014.302023 - PubMed
  30. D'Angelo H, Rolland B, Adsit R, et al. Tobacco treatment program implementation at NCI cancer centers: progress of the NCI Cancer Moonshot-funded Cancer Center Cessation Initiative. Cancer Prev Res (Phila). 2019;12:735-740. doi:10.1158/1940-6207.capr-19-0182 - PubMed
  31. Croyle RT, Morgan GD, Fiore MC. Addressing a core gap in cancer care-the NCI Moonshot program to help oncology patients stop smoking. N Engl J Med. 2019;380:512-515. doi:10.1056/nejmp1813913 - PubMed

Publication Types

Grant support